News

A new roadmap for preclinical and clinical trials investigating compounds to treat and prevent Parkinson’s disease was proposed by a team of international academic and industry researchers, the Alpha-Synuclein Clinical Path Working Group, in conjunction with the Michael J. Fox Foundation for Parkinson’s Research.

Parkinson’s News Today provided you with daily coverage of important findings, treatment developments, and clinical trials related to Parkinson’s during 2018. We look forward to bringing more news to Parkinson’s patients, as well as their family members and caregivers, during 2019.

A protein called Parkin, which is absent or faulty in many patients with early-onset Parkinson’s disease, helps keep cells alive and reduces the risk of inflammation, according to a recent study. These results suggest that the…

Parkinson Voice Project (PVP) is presenting a free educational lecture Jan. 12 in Richardson, Texas, for Parkinson’s disease patients and caregivers that will focus on nutritional health and disease management. Themed “Optimal Nutrition for Living Well with Parkinson’s,” the lecture will take place at 10:30 a.m. CT at PVP,…

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has granted a 2018 Therapeutic Pipeline Award to Progenra to support the company’s development of small molecule treatment candidates for Parkinson’s disease. “Progenra is pleased to have been selected by The Michael J. Fox Foundation to contribute…

Parkinson’s disease patients voluntarily controlled brainwaves associated with motor symptoms using a neurofeedback system, according to new research. These findings have implications for how to best harness brain activity and deep brain stimulation to treat Parkinson’s disease symptoms. The study, “Real-time neurofeedback to modulate…

Parkinson’s disease can sometimes mask the symptoms of other neurological disorders, according to a case report. The report, titled “NMDAR encephalitis presenting as akinesia in a patient with Parkinson disease,” documents the case of a 71-year-old woman who was eventually diagnosed with encephalitis, the symptoms…

Blocking a key enzyme responsible for the production of a type of fat can become a potential therapeutic approach to treat Parkinson’s disease, Yumanity Therapeutics recently announced. The company revealed that inhibiting an enzyme…

Supplements of omega-3 fatty acids and vitamin E may help control genes involved in brain inflammation and body metabolism in patients with Parkinson’s disease, a study has found. The study, “The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression related to inflammation, insulin…

Nicotine may protect the brain from manganese and iron metal trace elements thought to be involved in the onset of Parkinson’s disease, a study based on a disease cell model reported. The study, “Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson’s disease,” was published…